Author

D. Schmitz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:differential expression· 1

Frequent Co-Authors

C. Drosten· 2 shared E. Sanchez-Sendin· 2 shared H.-C. Kornau· 2 shared J. Kreye· 2 shared L. M. Jeworowski· 2 shared M. A. Homeyer· 2 shared M. L. Schmidt· 2 shared M. Yuan· 2 shared

Activity by Year

2018-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. Drosten

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

An organoid platform reveals MEK-PARP co-targeting to enhance radiation response in rectal cancer

Q. Xiao, J. E. Riedesser, T. Mulholland, Z. Li, J. Buchloh, P. Albrecht, M. Li, N. Venkatachalam, O. Skabkina, A. Klupsch, E. Eichhorn, L. Wang, S. Belle, N. Schulte, D. Schmitz, , J. Betge

The paper uses a patient-derived rectal cancer organoid platform to identify MEK and PARP inhibitors that synergize with radiation to enhance treatment response in locally advanced rectal cancer.

bioRxiv · Jun 6, 2024 · PreprintCancer Biology

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

S. M. Reincke, M. Yuan, H.-C. Kornau, V. M. Corman, S. van Hoof, E. Sanchez-Sendin, M. Ramberger, W. Yu, Y. Hua, H. Tien, M. L. Schmidt, T. Schwarz, L. M. Jeworowski, S. E. Brandl, H. Foverskov Rasmussen, , J. Kreye

SARS-CoV-2 Beta variant infection generates lineage-specific antibodies and cross-reactive antibodies with neutralizing activity against wild-type and other variants.

bioRxiv · Sep 30, 2021Immunology

A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model

J. Kreye, S. M. Reincke, H.-C. Kornau, E. Sanchez-Sendin, V. M. Corman, H. Liu, M. Yuan, N. C. Wu, X. Zhu, C.-C. D. Lee, J. Trimpert, M. Hoeltje, K. Dietert, L. Stoeffler, N. von Wardenburg, , N. Osterrieder

This study identifies a potent SARS-CoV-2 neutralizing antibody that protects hamsters from infection and lung damage.

bioRxiv · Aug 15, 2020Immunology

Molecular epidemiology of mumps viruses detected in the Netherlands, 2017-2019

R. Bodewes, L. Reijnen, J. Kerkhof, J. Cremer, D. Schmitz, R. van Binnendijk, I. Veldhuijzen

The paper analyzes mumps virus molecular epidemiology in the Netherlands 2017-2019, showing that complete genome sequencing provides better resolution than SH+NCRs sequencing.

bioRxiv · Apr 30, 2020Microbiology

Modular assembly of polysaccharide-degrading microbial communities in the ocean

T. N. Enke, M. S. Datta, J. Schwartzman, N. Cermak, D. Schmitz, J. Barrere, O. X. Cordero

This study shows that ocean polysaccharide-degrading microbial communities assemble in a modular fashion, with distinct primary degrader and broad-niche consumer modules, and validates this model using synthetic particles.

bioRxiv · Aug 8, 2018Microbiology